AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Oncolys BioPharma Inc.
  3. Financials
  4. Net income margin (%)

Oncolys BioPharma Inc.【JP:4588】

Market cap
¥67.6B
P/E ratio
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Dec 31, 2025-7,209.4+34.30%
Dec 31, 2024-5,368.3+74.57%
Dec 31, 2023-3,075.1+2512.76%
Dec 31, 2022-117.7-53.19%
Dec 31, 2021-251.4-62.30%
Dec 31, 2020-666.8+853.00%
Dec 31, 2019-70-90.44%
Dec 31, 2018-732+53.79%
Dec 31, 2017-476-8.87%
Dec 31, 2016-522.3-26.09%
Dec 31, 2015-706.7-72.46%
Dec 31, 2014-2,566.2-95.24%
Dec 31, 2013-53,860.4+207714.32%
Dec 31, 2012-25.9-421.18%
Dec 31, 20118.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)